This excerpt taken from the EYE 8-K filed Jan 27, 2009.
ITEM 7.01. Regulation FD.
On January 27, 2009, Advanced Medical Optics, Inc., a Delaware corporation (AMO), announced that it commenced a cash tender offer for its outstanding 7½% Senior Subordinated Notes due 2017 (the Notes) and a related consent solicitation to amend the indenture governing the Notes. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein. The tender offer is being conducted in connection with, and is conditioned on, among other things, the consummation of the pending acquisition of AMO by Abbott Laboratories.